Citations 2
Analysis of relationship between baseline body weight and efficacy/safety of yttrium 90 ( 90 Y) ibritumomab tiuxetan radioimmunotherapy in patients (pts) with non-Hodgkin's lymphoma (NHL)
Wiseman, Gregory A., Emmanouilides, Christos, Vo, Katie D. , Schilder, Russell J., Foster, Paul , Gordon, Leo I. , Witzig, Thomas E. , Molina, Aurelia Alañón
Journal of Clinical Oncology | April 5, 2017 | Volume: 22 | Issue: 14_suppl | Pages: 6700-6700
Low incidence of treatment-related myelodysplastic syndrome (tMDS) and acute myelogenous leukemia (tAML) in patients with non-Hodgkin's lymphoma (NHL) treated with ibritumomab tiuxetan
Emmanouilides, C., Czuczman, M. S., REVELL, S T, Wang, H. , Skikne, B. , Witzig, Thomas E. , Gordon, Leo I. , Foster, Paul , Molina, Aurelia Alañón
Journal of Clinical Oncology | April 5, 2017 | Volume: 22 | Issue: 14_suppl | Pages: 6696-6696